KINDEX PHARMACEUTICALS INC has a total of 18 patent applications. It increased the IP activity by 300.0%. Its first patent ever was published in 2011. It filed its patents most often in United States, Australia and China. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are AXEN BIO GROUP SP Z O O, ALECTRONA PTE LTD and SSV THERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 5 | |
#2 | Australia | 3 | |
#3 | China | 3 | |
#4 | EPO (European Patent Office) | 3 | |
#5 | Japan | 2 | |
#6 | Canada | 1 | |
#7 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Acyclic or carbocyclic compounds | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Organic chemistry methods |
# | Name | Total Patents |
---|---|---|
#1 | Urban Jan | 11 |
#2 | Desai Anuradha | 11 |
#3 | Konda Veera | 11 |
#4 | Dahlberg Clinton J | 10 |
#5 | Carroll Brian J | 9 |
#6 | Wolfe Andrew | 4 |
#7 | Grayson Neile | 4 |
#8 | Bland Jeffrey | 4 |
#9 | Wu Sheng | 4 |
#10 | Darland Gary | 3 |
Publication | Filing date | Title |
---|---|---|
KR20190138666A | Use of isofumulus and its derivatives for the treatment of polycystic ovary syndrome | |
US2015197472A1 | Methods of synthesizing alpha acids and substantially enantiomerically pure compositions thereof | |
CN107793307A | The derivative of tetrahydro-iso-humulone, method of manufacture and use thereof | |
AU2011320140A1 | Cis 3,4-dihydroxy-2-(3-methylbutanoyl)-5-(-3-methylbutyl)-4-(4-methylpentanoyl)cyclopent-2-en-1-one derivatives, substantially enantiomerically pure compositions and methods |